How can scientists use nontargeted metabolomics to compare drug-treated cells with untreated cells?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

Scientists use nontargeted metabolomics as a discovery tool to generate a broad portrait of cellular metabolism, allowing for a comprehensive comparison between drug-treated cells and untreated control cells.1

Unlike targeted approaches that focus on predefined panels of biochemicals, nontargeted metabolomics aims to identify metabolites that change in response to a specific condition. By measuring a wide array of molecular variables, researchers can observe how the cellular machinery shifts following drug exposure. This process is particularly valuable for identifying biochemical pathways affected by a drug, which can provide new insights into drug action, efficacy, and potential toxicity.12

Because this method often generates massive, high-dimensional data sets, researchers must apply rigorous statistical treatments to minimize the risk of false discoveries. By analyzing these metabolic profiles, scientists can better understand the mechanistic biochemistry underlying cellular responses, helping to distinguish between normal metabolic activity and changes induced by therapeutic or toxic agents.123